Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

© Springer Japan 2014. The discovery of IL-23 and characterization of the biology governed by this cytokine has led to dramatic new insights within immunology. IL-23 is central to the pathogenesis of many immune-mediated inflammatory disorders and was shown to act via a novel IL-17-producing T helper subset, the Th17 cell. Many innate cells also respond to IL-23 and are important in both resistance to infection and in mediating autoimmune pathology. These cells are characterized by ex pression of RORγt transcription regulator and include subsets of γδ T cells, natural killer (NK) cells, innate lymphoid cells in the intestine and a recently described entheseal resident cell that resides at a key site for rheumatic illness. Stimulation of these various cells by IL-23 induces severe inflammation, much of which is mediated by the signature cytokines, including IL-17 and IL-22. Exploration of the biology of IL-23 has thus led to the identification of novel immune cell subsets as well as new paradigms for disease localization based upon the distribution of IL-23- responder populations. These new concepts are at the core of novel therapeutic strategies based upon neutralization of IL-23 or IL-17, which are showing encouraging results for treatment of psoriasis, multiple sclerosis, rheumatoid arthritis, and ankylosing spondylitis.

Original publication

DOI

10.1007/978-4-431-54442-5_7

Type

Chapter

Book title

Cytokine Frontiers: Regulation of Immune Responses in Health and Disease

Publication Date

01/01/2014

Pages

179 - 198